SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-395498
Filing Date
2015-12-04
Accepted
2015-12-04 17:06:02
Documents
4
Period of Report
2015-12-04
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d22623d8k.htm 8-K 26976
2 EX-3.1 d22623dex31.htm EX-3.1 8626
3 EX-3.2 d22623dex32.htm EX-3.2 4261
4 EX-3.3 d22623dex33.htm EX-3.3 109524
  Complete submission text file 0001193125-15-395498.txt   151296
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 (816) 914-7027
Midatech Pharma US Inc. (Filer) CIK: 0000919745 (see all company filings)

IRS No.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23776 | Film No.: 151270718
SIC: 2834 Pharmaceutical Preparations